Press monitoring
Allergy's ragweed vaccine passes key trial
6.4.2006 | Press monitoring
Allergy Therapeutics received a boost today after the hay fever treatment outfit passed a key phase III clinical efficacy and safety trial for its ragweed allergy vaccine.
No winners in drug fight
6.4.2006 | Press monitoring
The protesters have had the chief executive in their sights for some time now. They've paraded outside his corporate offices. They've lobbied the companies he serves as a board member. They've flooded his phones with calls.
Antigen working with FDA to fast-track flu vaccine
6.4.2006 | Press monitoring
WORCESTER -- Antigen Express Inc. hopes to begin early-stage clinical trials as early as this fall on a synthetic peptide vaccine that could be made simply, quickly and in large quantities to help prepare for a possible avian flu pandemic.
rgistic Antitumor Effects of Immune Cell-Viral Biotherapy
6.4.2006 | Press monitoring
Targeted biological therapies hold tremendous potential for treatment of cancer, yet their use has been limited by constraints on delivery and effective tumor targeting.
Human chromosome 11 DNA sequence and analysis including novel gene identification
6.4.2006 | Press monitoring
Chromosome 11, although average in size, is one of the most gene- and disease-rich chromosomes in the human genome. Initial gene annotation indicates an average gene density of 11.6 genes per megabase, including 1,524 protein-coding genes, some of which were identified using novel methods, and 765 pseudogenes. One-quarter of the protein-coding...
Swiss researchers against TT ban
6.4.2006 | Press monitoring
Many Swiss Scientists are worried about the unscientific attitude of the Swiss Farmers’ Association and several Development Agencies and Environmental Groups.
Therapeutic short hairpin RNA expression in the liver: viral targets and vectors
6.4.2006 | Press monitoring
Over 500 million people worldwide are infected with one or more different and unrelated types of human hepatitis virus. Such individuals are at a high risk of developing acute or chronic hepatic disease, and ultimately dying from sequelae.
Do plants have the potential to vaccinate against HIV?
6.4.2006 | Press monitoring
Scientists have developed a new kind of molecule which they believe could ultimately lead to the development of a vaccine against HIV using genetically modified tobacco.
Protection of Plasminogen Activator Inhibitor-1-Deficient Mice from Nasal Allergy
6.4.2006 | Press monitoring
This study was performed to clarify the relationship between fibrinolytic components and the pathology of allergy, particularly that during the development of nasal allergy and nasal tissue changes.
Radical approach to protein damage
6.4.2006 | Press monitoring
Italian researchers have shown that Raman spectroscopy could be a useful tool in investigating radical-based damage to proteins.
